Monor, Hungary

Ferenc Tamás Takács

This inventor holds 1 USPTO granted patent. Top assignees: Pharmahungary 2000 Kft., Targetex Kft.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ferenc Tamás Takács. Retrieved from https://idiyas.com/inventor/ferenc-tamás-takács

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Ferenc Tamás Takács

Introduction

Ferenc Tamás Takács, an accomplished inventor based in Monor, Hungary, has made significant strides in the field of pharmaceuticals. His dedication to innovation is exemplified through his patent, which showcases his contributions to the advancement of medical science.

Latest Patents

Takács holds a notable patent titled "Inhibitors of matrix metalloproteinases - Compounds of general formula (I), salts or solvates thereof and pharmaceutical compositions containing same." This invention highlights his expertise in creating compounds that can potentially have a profound impact on medical treatments.

Career Highlights

Throughout his career, Ferenc Tamás Takács has worked with renowned companies such as Pharmahungary 2000 Ltd. and Targetex Ltd., where he contributed significantly to research and development. His experience within these organizations has bolstered his knowledge and skills in the pharmaceutical industry.

Collaborations

Takács has collaborated with notable professionals, including Péter Ferdinandy and Tamás Bálint Csont. These partnerships have allowed him to leverage diverse perspectives and expertise, further enhancing his innovative capabilities and contributing to successful projects in his field.

Conclusion

Ferenc Tamás Takács stands out as a prominent inventor whose work continues to influence the pharmaceutical landscape. His patent on matrix metalloproteinase inhibitors represents not only his innovation but also the collaborative spirit that drives advancements in medical science. As he continues to push boundaries, his contributions are poised to make a lasting impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…